The use of decentralized clinical trials is on the rise. They make participation more accessible, allow for remote data collection and greatly reduce or outright eliminate the need for in-person clinical visits. Common challenges that numerous therapeutic areas face, such as trial accessibility for participants with mobility issues can also be solved by DCTs. Still, there persists this notion that decentralized clinical trial expansion is more expensive. Read THREAD's report on the 5 Ways That Decentralized Clinical Trial Approaches Can Reduce Study Costs.
|
